PO Box 420, Kumeu, Auckland, New Zealand
[email protected]  |  0508-MEDICAL

Ordering and compliance portal:


  • Twitter
  • LinkedIn

© 2019 Zeacann Limited. All images © Zeacann unless otherwise indicated. 


Zeacann has ambitious plans to research and develop multiple product formulations and dose delivery methods, to better meet the needs of patients and health practitioners in New Zealand and globally.

Zeacann is patient-focused, and will operate to the highest standards of safety and assurance. Our partnership with Auckland University of Technology means we are uniquely positioned to develop novel formulations and delivery systems, bringing new products to market in line with patient needs.

In addition to direct manufacture and supply to pharmacies, Zeacann will also licence our unique IP (including cultivation and extraction technology, product formulations and dose delivery methods) to other licensed producers who have the ability to enter the market and can be complemented with our R&D expertise. 

Zeacann inteneds to produce a range of Cannabis-Based Products using sustainable methods and following operating procedures that are designed to produce standardised levels of Active Pharmaceutical Ingredients (API), such as THC and CBD.


Coming from New Zealand, Zeacann's products will naturally have a "Clean Green " image internationally, with cannabis grown from hydrocarbon-free, fully renewable sources. These will include:

  • Standardised herbal blends for vaporization

  • Oils, extractions and concentrates

  • Topical balms, lotions and patches for dermal absorption

  • Tablets and capsules for gastro absorption

  • Mouth sprays, lozenges, gums for sublingual absorption 

Zeacann owns the registered trademark Satinol®, which is intended to become a pharmaceutical range in a variety of formulations including oils, capsules and tablets. Mock representations of how Satinol® may appear are shown below. These do not represent actual products in our pipeline but are shown here  for illustrative purposes.

Show More
Show More

Zeacann will develop multiple retail brands to target different markets, uses, and price points, as well as supply unbranded semi-processed cannabis or refined ingredients.